Ignite Creation Date:
2025-12-24 @ 1:59 PM
Ignite Modification Date:
2026-01-08 @ 9:52 AM
Study NCT ID:
NCT03672695
Status:
COMPLETED
Last Update Posted:
2024-02-05
First Post:
2018-09-04
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Phase I Dose Escalation Study of Intravenously Administered S64315 in Combination With Orally Administered Venetoclax in Patients With Acute Myeloid Leukaemia.
Sponsor:
Institut de Recherches Internationales Servier
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2018-11-28
Start Date Type:
ACTUAL
Primary Completion Date:
2022-11-12
Primary Completion Date Type:
ACTUAL
Completion Date:
2023-05-30
Completion Date Type:
ACTUAL
First Submit Date:
2018-09-04
First Submit QC Date:
None
Study First Post Date:
2018-09-14
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-02-01
Last Update Post Date:
2024-02-05
Last Update Post Date Type:
ACTUAL